Jonathan Passeri is a Cardiology physician. OpenAlex indexes 139 publications with 6,837 citations (h-index 35).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St
Yaw 5a
Boston, MA 021142621
Telephone
617-726-2066Registry record last updated 18 Jul 2012.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20258 payments
- Edwards Lifesciences CorporationProgram year20253 payments
- Abbott LaboratoriesProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.9%Beta blocker25.1%Metoprolol Succinate86%Atenolol8%Carvedilol7%Part D<11 patientsStatin22.7%Atorvastatin Calcium78%Rosuvastatin Calcium14%Simvastatin5%Pravastatin Sodium3%Part D<11 patients+ 11 more classes in this area
Blood & clotting
13.7%Factor Xa inhibitor10.6%Eliquis85%Xarelto15%Part D<11 patientsVitamin K antagonist1.6%Warfarin Sodium100%Part D<11 patients+ 1 more class in this area
Anti-infectives
3.6%Penicillins with extended spectrum3.6%Amoxicillin100%Part D≥27 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study
European Heart Journal
2023 - Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology
2023 - Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation
JACC: Cardiovascular Interventions
2022 - Trends in Utilization of Aortic Valve Replacement for Severe Aortic Stenosis
Journal of the American College of Cardiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”